On Demand
1hr 59 min
Share webinar
![](https://framerusercontent.com/images/4nyjOLiwPGg3520zNUjC0yDlBFs.webp)
Comprehensive genomic profiling is essential for precision oncology. The speakers evaluated cancer gene panels on MGI's G400 and G99 DNBSEQ systems. Agilent's assay offers tumor profiling on G400; GenePLUS has a 1021-gene panel; NGeneBio targets 18-343 genes for various cancers. These systems achieve >90% Q30, >50X coverage, detecting variants down to 1% allele frequency. MGI's systems offer speed, scalability, and cost-effectiveness, supporting both large and targeted panels for cancer research and diagnostics, advancing genomic medicine.
![William TAN, PhD BCMAS](https://framerusercontent.com/images/1WuFwb12c5LZkWAFHMF9cgCEZ1Y.webp)
Dr. William Tan Associate Director @MiRXES
![Dr. Michael Ruvolo Director, R&D @Agilent Technologies](https://framerusercontent.com/images/bvjNAKl3pUOOFq6XTgA4eGlK4.webp)
Dr. Michael Ruvolo Director, R&D @Agilent Technologies
![Xiaorui (Harry) Han](https://framerusercontent.com/images/ZeeOwaDdQGEfvs2NiNMk9p0uom8.webp)
Dr. Xiaorui Han Overseas Product Manager @Geneplus
![Dr. Felicity Hall Senior Global Product Manager @Agilent Technologies](https://framerusercontent.com/images/KoxZinH15mxYIMdFUCqW7uYSmfQ.webp)
Dr. Felicity Hall Senior Global Product Manager @Agilent Technologies
![Dr. Kathy K.S. Lee Team leader @NGeneBio](https://framerusercontent.com/images/X52m2JUnOfR4G0ZGSYDXzjZQRmM.webp)
Dr. Kathy K.S. Lee Team leader @NGeneBio